智通财经APP获悉，3月20日，医渡科技(02158)延续常态化价值回购，当日耗资500余万港元回购股份，以连贯且坚定的资本动作，持续传递对公司内在价值、AI医疗长期赛道的十足信心。
作为港股AI医疗回购第一股，公司年内回购表现领跑全市场，累计回购34次，累计耗资已超2.4亿港元，高频大额的回购力度树立港股医疗科技板块价值标杆，叠加高库存股占比支撑，财务稳健性与长期价值底气进一步凸显。
业务端同步抢占行业高地，重磅亮相行业顶级盛会。近日医渡科技携全链路临研AI解决方案，亮相CMAC创新药物医学大会，举办专场学术沙龙共探AI重塑CRO新范式，现场展示多项AI赋能药物研发的核心成果，高效赋能临床研究提质降本，加速AI技术在药物研发、临床科研场景的规模化落地，进一步巩固行业技术领先优势。
资本端坚定回购稳预期，业务端行业发声强壁垒。医渡科技将持续以“资本+技术+场景”三轮驱动，深耕AI医疗核心赛道，释放长期成长动能，切实回馈投资者与市场信任。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.